Literature DB >> 24952781

Invited review: effect, persistence, and virulence of coagulase-negative Staphylococcus species associated with ruminant udder health.

W Vanderhaeghen1, S Piepers1, F Leroy2, E Van Coillie3, F Haesebrouck4, S De Vliegher5.   

Abstract

The aim of this review is to assess the effect of coagulase-negative staphylococci (CNS) species on udder health and milk yield in ruminants, and to evaluate the capacity of CNS to cause persistent intramammary infections (IMI). Furthermore, the literature on factors suspected of playing a role in the pathogenicity of IMI-associated CNS, such as biofilm formation and the presence of various putative virulence genes, is discussed. The focus is on the 5 CNS species that have been most frequently identified as causing bovine IMI using reliable molecular identification methods (Staphylococcus chromogenes, Staphylococcus simulans, Staphylococcus haemolyticus, Staphylococcus xylosus, and Staphylococcus epidermidis). Although the effect on somatic cell count and milk production is accepted to be generally limited or nonexistent for CNS as a group, indications are that the typical effects differ between CNS species and perhaps even strains. It has also become clear that many CNS species can cause persistent IMI, contrary to what has long been believed. However, this trait appears to be quite complicated, being partly strain dependent and partly dependent on the host's immunity. Consistent definitions of persistence and more uniform methods for testing this phenomenon will benefit future research. The factors explaining the anticipated differences in pathogenic behavior appear to be more difficult to evaluate. Biofilm formation and the presence of various staphylococcal virulence factors do not seem to (directly) influence the effect of CNS on IMI but the available information is indirect or insufficient to draw consistent conclusions. Future studies on the effect, persistence, and virulence of the different CNS species associated with IMI would benefit from using larger and perhaps even shared strain collections and from adjusting study designs to a common framework, as the large variation currently existing therein is a major problem. Also within-species variation should be investigated.
Copyright © 2014 American Dairy Science Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biofilm; coagulase-negative staphylococci (CNS); effect; intramammary infection; persistence; virulence

Mesh:

Substances:

Year:  2014        PMID: 24952781     DOI: 10.3168/jds.2013-7775

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  28 in total

1.  Staphylococcus chromogenes, a Coagulase-Negative Staphylococcus Species That Can Clot Plasma.

Authors:  Danielle Cabral Dos Santos; Carla Christine Lange; Pedro Avellar-Costa; Katia Regina Netto Dos Santos; Maria Aparecida Vasconcelos Paiva Brito; Marcia Giambiagi-deMarval
Journal:  J Clin Microbiol       Date:  2016-02-24       Impact factor: 5.948

2.  Coagulase-negative Staphylococci favor conversion of arginine into ornithine despite a widespread genetic potential for nitric oxide synthase activity.

Authors:  María Sánchez Mainar; Stefan Weckx; Frédéric Leroy
Journal:  Appl Environ Microbiol       Date:  2014-10-03       Impact factor: 4.792

3.  Diverse β-lactam antibiotic-resistant bacteria and microbial community in milk from mastitic cows.

Authors:  Zhengxin Ma; Shinyoung Lee; Peixin Fan; Yuting Zhai; Jaehyun Lim; Klibs N Galvão; Corwin Nelson; Kwangcheol Casey Jeong
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-15       Impact factor: 4.813

4.  Efficacy of MALDI-TOF mass spectrometry as well as genotypic and phenotypic methods in identification of staphylococci other than Staphylococcus aureus isolated from intramammary infections in dairy cows in Poland.

Authors:  Anna Wanecka; Jarosław Król; Jan Twardoń; Jacek Mrowiec; Agnieszka Korzeniowska-Kowal; Anna Wzorek
Journal:  J Vet Diagn Invest       Date:  2019-04-22       Impact factor: 1.279

5.  Persistence of Staphylococcus spp. in milk from cows undergoing homeopathy to control subclinical mastitis.

Authors:  Elka Machado Ferreira; Letícia Castilho Romero; Maria de Lourdes Ribeiro de Souza da Cunha; Wilson Malagó Junior; Carlos Henrique Camargo; Waldomiro Barioni Júnior; Luiz Francisco Zafalon
Journal:  BMC Vet Res       Date:  2022-07-13       Impact factor: 2.792

6.  Local host response following an intramammary challenge with Staphylococcus fleurettii and different strains of Staphylococcus chromogenes in dairy heifers.

Authors:  Kristine Piccart; Joren Verbeke; Anneleen De Visscher; Sofie Piepers; Freddy Haesebrouck; Sarne De Vliegher
Journal:  Vet Res       Date:  2016-05-12       Impact factor: 3.683

7.  Species distribution and in vitro antimicrobial susceptibility of coagulase-negative staphylococci isolated from bovine mastitic milk.

Authors:  Suvi Taponen; Suvi Nykäsenoja; Tarja Pohjanvirta; Anna Pitkälä; Satu Pyörälä
Journal:  Acta Vet Scand       Date:  2016-02-06       Impact factor: 1.695

8.  Comprehensive Phylogenetic Analysis of Bovine Non-aureus Staphylococci Species Based on Whole-Genome Sequencing.

Authors:  Sohail Naushad; Herman W Barkema; Christopher Luby; Larissa A Z Condas; Diego B Nobrega; Domonique A Carson; Jeroen De Buck
Journal:  Front Microbiol       Date:  2016-12-20       Impact factor: 5.640

9.  Tetracycline resistance phenotypes and genotypes of coagulase-negative staphylococcal isolates from bubaline mastitis in Egypt.

Authors:  K A Abd El-Razik; A A Arafa; R H Hedia; E S Ibrahim
Journal:  Vet World       Date:  2017-06-25

10.  Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South India.

Authors:  P L Preethirani; Shrikrishna Isloor; S Sundareshan; V Nuthanalakshmi; K Deepthikiran; Akhauri Y Sinha; D Rathnamma; K Nithin Prabhu; R Sharada; Trilochan K Mukkur; Nagendra R Hegde
Journal:  PLoS One       Date:  2015-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.